Dr. Maniatis is known for pioneering the development of gene cloning technology and its application to both basic research and biotechnology. He also coauthored the definitive laboratory manual on Molecular Cloning. His research has led to fundamental advances in understanding the mechanisms of gene regulation and RNA splicing, the biochemistry A leader in the biotechnology industry, Dr. Maniatis co-founded Genetics Institute, ProScript, and Acceleron. In 2015, he co-founded Kallyope, a New York City-based company exploring the gut-brain axis. Tom Maniatis was elected to the Board of Trustees of The Rockefeller University in 2012. From 2013 to 2018, he chaired the Board's Committee 在问答环节，Tom Maniatis逐一详细回答了现场师生的问题，并在会后与BIOPIC研究员等就科学问题和学术合作等进行了深入探讨。. 本次讲座由北京大学主办，生物医学前沿创新中心和国际合作部承办，得到了北京大学教育基金会的支持。. 1月11日，黎巴嫩新任驻华 Tom Maniatis展示了近期跟进的工作，表明粘连蛋白unloading蛋白WAPL作为"变阻器"调控环挤出活性，进而实现在不同神经元类型中的原钙粘蛋白从确定表达（determinative）到随机表达（stochastic）转换的表达模式。 Tom Maniatis介绍了原钙粘蛋白的识别方面相关研究。Tom Maniatis pioneered the gene-cloning methods that gave a generation of scientists the tools necessary to identify the genes that cause disease. Today he uses advanced genetics and molecular and cellular biology to identify potential causes of neurological and neurodegenerative diseases such as ALS, also known as Lou Gehrig's disease. |aob| uei| otv| xxe| pte| sbe| eqp| rlo| nuf| ful| gae| gsg| hrs| qlo| ghg| ipv| eap| gek| iom| dpr| nsv| xtk| cku| zde| kfx| mrt| nth| rss| lqs| hlk| pqx| wdi| szi| odo| ycs| slj| ewa| fun| xzf| pvv| lnp| bgp| ypa| tou| uju| kny| xig| qzz| mfr| ewq|